• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CERAPEDICS INC. I-FACTOR PUTTY; FILLER, BONE VOID, SYNTHETIC PEPTIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CERAPEDICS INC. I-FACTOR PUTTY; FILLER, BONE VOID, SYNTHETIC PEPTIDE Back to Search Results
Model Number 700-050
Device Problem Migration (4003)
Patient Problem Seroma (2069)
Event Type  Injury  
Event Description
Surgeon stated that he has had a couple compressive seromas on consecutive posterior lateral patients.When opening the wound ifactors was found.This concerned him.Required return to or.Report for 2 of 2 surgeries reported.
 
Manufacturer Narrative
Complaint investigation ongoing.Will review manufacturing records, similar complaints, ifu and risk anaylsis.
 
Manufacturer Narrative
Device history record the design history record was reviewed for lot 23c1551 and indicated no abnormal processing.The lot in question met all specifications prior to its release.Aside from the associated complaint from dr.Sebastian (c24-160), no other complaints have been received for lot 23c1551.Capas and ncrs associated with lot there have been no ncrs or capas associated with this lot.Risk analysis and previous complaints cerapedics risk analysis document ra-001, revision 23 (putty) was reviewed.The failure mode identified in this complaint is already identified under line item 40 - "wound complications including hematoma, site drainage, and infection." therefore, no updates to the risk assessment are required.There have been 3 (three) previous complaints related to this potential failure mode.Based on the total number of units distributed (n=286,101), the observed rate is 0.001%.The mitigated risk probability for this potential failure mode is estimated to be 2 or an estimated occurrence rate of 0.25%.Therefore, the benefit-risk analysis remains unchanged.Us putty ifu ((b)(4)) lists the following under potential adverse events: "wound complications including hematoma, site drainage, infection, dehiscence and/pr necrosis".As such, no updates are required for the ifu.Conclusion based on the information available, no causal link could be established between i-factor putty and the reported complaint.Other potential contributing factors to consider are the surgical technique used, the patient's physiology/condition, and/or concomitant devices used for the surgery.The ifu clearly lists wound complications as a potential adverse event; therefore, no additional action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-FACTOR PUTTY
Type of Device
FILLER, BONE VOID, SYNTHETIC PEPTIDE
Manufacturer (Section D)
CERAPEDICS INC.
11025 dover street
suite #1600
westminster CO 80021
Manufacturer Contact
emily aulby
11025 dover street
suite #1600
westminster, CO 80021
MDR Report Key18886823
MDR Text Key337452329
Report Number3007155473-2024-24163
Device Sequence Number1
Product Code NOX
Combination Product (y/n)Y
PMA/PMN Number
P140019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/12/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model Number700-050
Device Lot Number23C1551
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/18/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-